Improved Outcomes of Patients with End-stage Cystic Fibrosis Requiring Invasive Mechanical Ventilation for Acute Respiratory Failure
- 182 Downloads
The aim of this study was to determine the effects of an antibiotic strategy with intravenous (IV) continuous infusion of a β-lactam (CIBL) antibiotic and high-dose extended-interval (HDEI) tobramycin upon outcomes in patients with cystic fibrosis (CF) requiring invasive mechanical ventilation (IMV) for acute respiratory failure.
The study was a retrospective review from June 1, 2006, to December 1, 2010, of patients at a university hospital with an adult CF center.
The study population included adult CF patients requiring IMV. A total of 15 hospitalizations with IMV episodes were reviewed, involving 10 adult (31.4 ± 11.1 years) CF patients with end-stage lung disease (FEV1 = 23.6 ± 7.8% predicted) and malnutrition (body mass index = 20.5 ± 3.1). Each patient survived to discharge and to follow-up 6 months later without the need for lung transplantation during the study period.
A novel antibiotic strategy with a CIBL antibiotic and HDEI tobramycin improved survival in a small cohort of critically ill CF patients with end-stage lung disease and malnutrition requiring IMV.
KeywordsCystic fibrosis Invasive mechanical ventilation Continuous infusion β-Lactam antibiotic Respiratory failure Tobramycin Pseudomonas aeruginosa
The authors greatly appreciated the outstanding assistance of Linda Combs in the preparation and development of the manuscript.
There are no conflicts of interest to declare.
- 5.Davis PB (1999) Clinical pathophysiology and manifestations of lung disease. In: Yankaskas JR, Knowles MR (eds) Cystic fibrosis in adults, 1st edn. Lippincott-Raven, Philadelphia, pp 45–67Google Scholar
- 17.Roosendaal R, Bakker-Woudenberg IA, Van den Berghe Van-Raffe M, Vink-van den Berg JC, Michel BM (1989) Impact of the dosage schedule on the efficacy of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats. Eur J Clin Microbiol Infect Dis 8:878–887PubMedCrossRefGoogle Scholar
- 24.Lau WK, Mercer D, Itani KM et al (2006) Randomized, open-label, comparative study of piperacillin-tazobactam administered by continuous infusion versus intermittent infusion for treatment of hospitalized patients with complicated intra-abdominal infection. Antimicrob Agents Chemother 50:3556–3561PubMedCrossRefGoogle Scholar
- 41.Smyth AR, Bhatt J (2010) Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis. Cochrane Database Syst Rev (1):CD002009Google Scholar